Addex Therapeutics Raises $2.8M Gross Proceeds Through ATM Sale Of 437,869 ADSs, Extends Cash Runway To Q4 2027
Share
Why It Matters
Addex raised money by selling shares to investors, which gives them cash to keep running their business until late 2027. When a company does this, watch whether they spend the money wisely on new medicines or if they run out of cash anyway.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.